Future costs and the future of cost-effectiveness analysis

被引：19

|

作者：

Garber, Alan M. ^{[1
,2
]}

Phelps, Charles E. ^{[3
]}

机构：

[1] Stanford Univ, Ctr Primary Care & Outcomes Res, Ctr Hlth Policy, Stanford, CA 94305 USA

[2] VA Palo Alto Hlth Care System, Palo Alto, CA USA

[3] Univ Rochester, Rochester, NY 14627 USA

来源：

JOURNAL OF HEALTH ECONOMICS | 2008年 / 27卷 / 04期

关键词：

D O I：

10.1016/j.jhealeco.2008.05.002

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

收藏

页码：819 / 821

页数：3

相关论文

共 50 条

[21] PREVALENT AND MULTIPLE FUTURE INCIDENT COHORTS IN COST-EFFECTIVENESS ANALYSIS
Hoyle, M.
Anderson, R.
VALUE IN HEALTH, 2008, 11 (06) : A562 - A562
[22] Accounting for Nonhealth and Future Costs in Cost-Effectiveness Analysis: Distributional Impacts of a US Cancer Prevention Strategy
Kim, David D.
PHARMACOECONOMICS, 2023, 41 (9) : 1151 - 1164
[23] Accounting for Nonhealth and Future Costs in Cost-Effectiveness Analysis: Distributional Impacts of a US Cancer Prevention Strategy
David D. Kim
PharmacoEconomics, 2023, 41 : 1151 - 1164
[24] Costs and thresholds in cost-effectiveness analysis
Sartore, M. E.
Kamal, K. M.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (10) : 1455 - 1456
[25] Survivor costs in cost-effectiveness analysis
Gandjour, A
ANNALS OF INTERNAL MEDICINE, 2006, 144 (07) : 534 - 535
[26] Indirect costs and cost-effectiveness analysis
Ernst, Richard
VALUE IN HEALTH, 2006, 9 (04) : 253 - 261
[27] Estimating 'costs' for cost-effectiveness analysis
Miners, Alec
PHARMACOECONOMICS, 2008, 26 (09) : 745 - 751
[28] Estimating ‘Costs’ for Cost-Effectiveness Analysis
Alec Miners
PharmacoEconomics, 2008, 26 : 745 - 751
[29] Cost-effectiveness analysis and capital costs
Karlsson, G
Johannesson, M
SOCIAL SCIENCE & MEDICINE, 1998, 46 (09) : 1183 - 1191
[30] The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS
Perry-Duxbury, Megan
Lomas, James
Asaria, Miqdad
van Baal, Pieter
PHARMACOECONOMICS, 2022, 40 (02) : 233 - 239

← 1 2 3 4 5 →